Pharmaceutical Company Ultragenyx Agrees
Outcome
OIG enforcement action against Pharmaceutical Company Ultragenyx Agrees for false claims, kickbacks. Penalty: $6 million.
Details
Pharmaceutical Company Ultragenyx Agrees — OIG Enforcement (2026)
OIG took enforcement action against Pharmaceutical Company Ultragenyx Agrees in 2026 involving false claims, kickbacks violations in the Independent Pharmacies sector.
Penalty: $6 million
Violation types: False Claims, Kickbacks
Entity type: Pharmacy
Penalty type: Settlement
Source: Pharmaceutical Company Ultragenyx Agrees to Pay $6 Million for Allegedly Paying Kickbacks to Induce Claims for Its Drug Crysvita
How Crucible Prevents This
Crucible's billing compliance controls enforce documentation-to-claims reconciliation, requiring clinical attestation before claims submission and flagging billing patterns that deviate from documented care delivery. Crucible's referral monitoring tracks patient source patterns and flags arrangements that correlate referral volume with financial relationships, enforcing anti-kickback compliance documentation.
Don't let this happen to your organization. See how Crucible works.
See How Crucible Works